Previous investigators have proposed that CD34 loss is associated with the malignant progression in several mesenchymal tumors such as dermatofibrosarcoma protuberans15, 16, solitary fibrous tumors17, 18, and phyllodes tumors19–21. This evidence concerns the gene CD34 and mesenchymal cell neoplasm.